We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-2.1%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.12B
AUM Growth
-$506M
Cap. Flow
-$1.33B
Cap. Flow %
-25.88%
Top 10 Hldgs %
36.5%
Holding
171
New
28
Increased
20
Reduced
18
Closed
38

Top Buys

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$561M
2
WGS icon
GeneDx Holdings
WGS
+$144M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$39.4M
4
GKOS icon
Glaukos
GKOS
+$34.3M
5
AERI
Aerie Pharmaceuticals
AERI
+$31.4M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$54.4M
2
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$54.1M
3
QDEL icon
QuidelOrtho
QDEL
+$52.4M
4
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$45.3M
5
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$42.5M

Sector Composition

Rank Sector Weight
1 Healthcare 66.12%
2 Financials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLTH
76
DELISTED
Cue Health Inc. Common Stock
HLTH
$9.44M 0.18%
+798,867
New +$12.6M
AUPH icon
77
PUT
Aurinia Pharmaceuticals
AUPH
$1.99B
$9.41M 0.18%
+425,300
New +$6.75M
AMWL icon
78
American Well
AMWL
$184M
$9.03M 0.18%
49,556
– –
GHRS icon
79
GH Research
GHRS
$1.92B
$8.94M 0.17%
405,416
-150,000
-27% -$3.05M
NYXH
80
Nyxoah
NYXH
$143M
$8.8M 0.17%
+300,800
New +$9.52M
AVAH icon
81
Aveanna Healthcare
AVAH
$2.11B
$8.12M 0.16%
1,013,007
-986,993
-49% -$9.57M
OLMA icon
82
Olema Pharmaceuticals
OLMA
$1.09B
$7.47M 0.15%
271,191
– –
TMPMU
83
DELISTED
Turmeric Acquisition Corp. Unit
TMPMU
$7.45M 0.15%
750,000
– –
PKBO
84
DELISTED
Peak Bio, Inc. Common Stock
PKBO
$7.1M 0.14%
+725,000
New +$7.03M
PRVA icon
85
Privia Health
PRVA
$3.16B
$7.07M 0.14%
300,000
– –
CVRX icon
86
CVRx
CVRX
$127M
$6.84M 0.13%
413,747
+13,747
+3% +$264K
BDTX icon
87
Black Diamond Therapeutics
BDTX
$101M
$6.43M 0.13%
760,128
-287,471
-27% -$2.84M
OKUR
88
OnKure Therapeutics
OKUR
$163M
$6.33M 0.12%
84,930
– –
CABA icon
89
Cabaletta Bio
CABA
$452M
$5.64M 0.11%
464,252
– –
TPTX
90
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$5.57M 0.11%
83,846
– –
DCTH icon
91
Delcath Systems
DCTH
$414M
$5.22M 0.1%
500,000
– –
OHPA
92
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
$4.85M 0.09%
+500,000
New +$4.87M
IRTC icon
93
iRhythm Holdings
IRTC
$3.72B
$3.53M 0.07%
+60,271
New +$3.19M
BCRX icon
94
BioCryst Pharmaceuticals
BCRX
$2.48B
$3.37M 0.07%
234,643
-2,600,357
-92% -$41M
MDVL
95
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$3.34M 0.07%
22,851
– –
TALK icon
96
Talkspace
TALK
$874M
$2.74M 0.05%
750,000
– –
BFLY.WS
97
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$2.02M 0.04%
733,333
– –
TOIIW
98
The Oncology Institute Warrant
TOIIW
$2.01M 0.04%
1,250,000
– –
CMAXW
99
DELISTED
CareMax, Inc. Warrant
CMAXW
$1.9M 0.04%
672,000
– –
MAACW
100
DELISTED
Montes Archimedes Acquisition Corp. Warrant
MAACW
$1.49M 0.03%
+1,000,000
New +$1.35M
2 3
4
5 6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2021 Portfolio in Review

As of Q3 2021, Deerfield Management held 171 positions worth $5.12B, down 9% from $5.63B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Deerfield Management withdrew a net $1.33B in Q3 2021, closing 38 positions and reducing 18 holdings. Its most notable exit was Zimmer Biomet, an estimated $54.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 68% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in Nuvalent worth $436M.

  • Deerfield Management's largest Q3 2021 buy was Nuvalent: 19,341,024 shares worth $436M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2021, an estimated $39.4M increase.
  • Deerfield Management's biggest Q3 2021 reduction was BioCryst Pharmaceuticals, cutting an estimated $41M.
  • Deerfield Management fully exited Zimmer Biomet in Q3 2021, selling an estimated $54.4M.
  • Deerfield Management's ten largest holdings make up 37% of its $5.12B portfolio in Q3 2021.
  • Deerfield Management opened 28 new positions and closed 38 in Q3 2021.
  • Deerfield Management's portfolio value fell 9% quarter-over-quarter to $5.12B.

Based on Deerfield Management's 13F filing for Q3 2021, filed 15 Nov 2021.